Amylin Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Amylin Pharmaceuticals Ownership

Who owns Amylin Pharmaceuticals?

Amylin Pharmaceuticals is owned by Bristol-Myers Squibb. It was acquired on June 29, 2012.

Amylin Pharmaceuticals Business Overview

Where is Amylin Pharmaceuticals headquartered?

Amylin Pharmaceuticals is headquartered in San Diego, California.

How many employees does Amylin Pharmaceuticals have?

Amylin Pharmaceuticals has 1,300 employees.

What sector is Amylin Pharmaceuticals in?

Amylin Pharmaceuticals is a life science company.

When was Amylin Pharmaceuticals founded?

Amylin Pharmaceuticals was founded in 1987.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

Amylin Pharmaceuticals LLC

9360 Towne Centre Drive,
San Diego, California 92121
United States,
(858)552-2200
www.amylin.com

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company developing drugs for the treatment of diabetes, obesity, and cardiovascular disease.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.